Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Delegation to Israel

Reference number
Coordinator EQ Research & Development AB
Funding from Vinnova SEK 19 696
Project duration November 2022 - November 2022
Status Completed

Important results from the project

** Denna text är maskinöversatt ** The goal of the delegation trip was to increase the Swedish state of knowledge in Israeli innovation, innovation structure, various financing opportunities, and general collaborations. The delegation trip fulfilled the objective beyond expectations and possible future collaborations are discussed within different levels.

Expected long term effects

** Denna text är maskinöversatt ** The delegation trip was carried out in connection with Innovate beyond borders (HealthIL), which is Israel´s largest innovation event in healthcare. The delegation trip has created contacts with Israeli start-up organizations, incubators, innovation departments mainly within healthcare (for example hospitals) and at the authority level. The delegation trip will probably result in the majority of XBRX000 future collaborations for increased knowledge dissemination.

Approach and implementation

** Denna text är maskinöversatt ** Layout and implementation - analysis * The delegation trip was arranged by Vinnova. It was a full programme, where the delegation visited many organizations within Israeli innovation with a focus on healthcare. We visited both privately and publicly run hospitals, incubators, accelerators, and gained insights into several different funding functions. In addition, the delegation also participated in Innovate beyond borders (HealthIL), which is Israel´s largest innovation event in healthcare.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 18 April 2023

Reference number 2022-03423